top of page
Search Results
All (7)
Posts (2)
Other Pages (5)
Results found for "GlaxoSmithKline"
Posts (2)
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
Previous companies worked at include OrthoBiotech (OBI), a division of Johnson & Johnson and GlaxoSmithKline
- First in Human: Early-stage COVID therapies hold promise against omicron variant
race to test their shots against the variant, the monoclonal antibody sotrovimab from Vir and partner GlaxoSmithKline
Other Pages (5)
- Dr. Terry Kenakin | Dr. GPCR Ecosystem
in RTP where he remained for 25 years through iterations of Glaxo Inc, GlaxoWellcome , and finally GlaxoSmithKline
- Chris Langmead | Dr. GPCR Ecosystem
Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009).
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
He spent 25 years in drug discovery at Glaxo (now GlaxoSmithKline) before joining UNC Chapel Hill, where
bottom of page